• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing

    11/19/21 9:54:00 AM ET
    $AIH
    $AZN
    $BLCT
    $BTCM
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIH alert in real time by email

    NEW YORK, Nov. 19, 2021 /PRNewswire/ -- Deutsche Bank today announced that the presentations from the November 16th and 17th  Depositary Receipts Virtual Investor Conference ("dbVIC") are now available for on-demand viewing. The event featured presentations from international companies with American Depositary Receipt (ADR) programs in the US.

    Representatives from participating companies based in Australia, China, Germany, France and the UK presented their equity stories and answered audience questions. The presentations are targeted to all types of investors as well as analysts interested in non-US companies.

    To log in, please use the following link: www.adr.db.com/dbvic 

    The company presentations will be available 24/7 for 90 days. Investors, advisors and analysts may download shareholder materials from the "virtual trade booth" for the next three weeks.

    The following companies participated in the conference:

    • Hywin ((HYW)
    • First Pacific ((Hong Kong: 142_HK, OTC:FPAFY)
    • Telstra ((Australia: TLS, OTC:TLSYY)
    • BlueCity Holdings ((BLCT)
    • Yiren Digital ((YRD)
    • Ecofibre ((Australia: EOF, OTC:EOFBY)
    • Ipsen ((Paris: IPN, OTC:IPSEY)
    • Travis Perkins ((London: TPK, OTC:TPRKY)
    • HUTCHMED ((HCM, London: HCM))
    • China Online Education ((COE)
    • NIO ((NIO)
    • Aesthetic Medical International Holdings ((AIH)
    • Quhuo ((QH)
    • AstraZeneca ((London: AZN, NASDAQ:AZN)
    • BIT Mining ((BTCM)
    • Hugo Boss ((Germany: BOSS, OTC:BOSSY)

    In addition to specializing in administering cross-border equity structures such as American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. The Bank offers a broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.

    Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany's leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.

    Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes. Deutsche Bank does not prepare, review, approve or edit any presentations, statements, documents or other information or materials, whether in written, electronic or verbal form, provided by any company participating in such conference, and disclaims any responsibility for the accuracy or adequacy of any such information or materials. Deutsche Bank is not promoting, endorsing or recommending any company participating in the conference.

    The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act"). The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant or in any way represent, as to the accuracy or completeness of the details contained herein or therein. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities nor does it constitute a solicitation to any person in any jurisdiction where solicitation would be unlawful. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© November 2021 Deutsche Bank AG. All rights reserved.

    Cision View original content:https://www.prnewswire.com/news-releases/deutsche-banks-depositary-receipts-virtual-investor-conference-presentations-now-available-for-on-demand-viewing-301429119.html

    SOURCE dbVIC - Deutsche Bank Depositary Receipts Virtual Investor Conference

    Get the next $AIH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIH
    $AZN
    $BLCT
    $BTCM

    CompanyDatePrice TargetRatingAnalyst
    AstraZeneca PLC
    $AZN
    1/27/2026Buy
    Citigroup
    NIO Inc.
    $NIO
    1/15/2026$6.10Neutral → Outperform
    Macquarie
    NIO Inc.
    $NIO
    11/25/2025Outperform → Neutral
    Macquarie
    AstraZeneca PLC
    $AZN
    10/27/2025Buy
    Jefferies
    AstraZeneca PLC
    $AZN
    10/16/2025Hold → Sell
    Deutsche Bank
    NIO Inc.
    $NIO
    9/23/2025$8.10 → $8.60Buy
    Citigroup
    HUTCHMED (China) Limited
    $HCM
    9/22/2025$13.75Equal-Weight → Underweight
    Morgan Stanley
    NIO Inc.
    $NIO
    9/16/2025$8.50Neutral → Buy
    UBS
    More analyst ratings

    $AIH
    $AZN
    $BLCT
    $BTCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on AstraZeneca

    Citigroup initiated coverage of AstraZeneca with a rating of Buy

    1/27/26 8:43:14 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NIO upgraded by Macquarie with a new price target

    Macquarie upgraded NIO from Neutral to Outperform and set a new price target of $6.10

    1/15/26 2:18:27 PM ET
    $NIO
    Auto Manufacturing
    Industrials

    NIO downgraded by Macquarie

    Macquarie downgraded NIO from Outperform to Neutral

    11/25/25 2:54:11 PM ET
    $NIO
    Auto Manufacturing
    Industrials

    $AIH
    $AZN
    $BLCT
    $BTCM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AstraZeneca results: FY and Q4 2025

    Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period AstraZeneca: Revenue and EPS summary   FY 2025 % Change Q4 2025 % Change   $m Actual CER1 $m Actual CER - Product Sales 55,573 9 9 14,538 9 7 - Alliance Revenue 3,067 39 38 959 34 33 Product Revenue2 58,640 10 10 15,497 10 8 Collaboration Revenue 99 (89) (89) 6 (99) (99) Total Revenue 58,739 9 8 15,503 4

    2/10/26 7:00:00 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HUTCHMED to Announce 2025 Final Results

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2025 on Thursday, March 5, 2026 at 6:00 am Eastern Standard Time (EST) / 11:00 am Greenwich Mean Time (GMT) / 7:00 pm Hong Kong Time (HKT). HUTCHMED management will host two webcast presentations for analysts and investors to discuss the final results, followed by Q&A sessions. The English webcast will be held on Thursday, March 5, 2026, at 8:00 am EST (1:00 pm GMT / 9:00 pm HKT). The Chinese (Putonghua) webcast will be held at 8:30 am HKT / 12:30 am GMT on Friday, March 6, 202

    2/6/26 3:30:00 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NIO Inc. Announces Profit Alert for the Fourth Quarter of 2025

    SHANGHAI, Feb. 05, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE:NIO, HKEX: 9866, SGX: NIO)) ("NIO" or the "Company"), a pioneer and a leading company in the global smart electric vehicle market, today announced a profit alert for the fourth quarter of 2025. The board of directors of the Company (the "Board") wishes to inform shareholders and potential investors that, based on a preliminary assessment of the Company's unaudited consolidated management accounts and the information currently available to the Board, the Company is expected to achieve an adjusted profit from operations (non-GAAP) in the range of approximately RMB700 million (approximately US$100 million)i to RMB1,200 million (appro

    2/5/26 5:00:00 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    $AIH
    $AZN
    $BLCT
    $BTCM
    SEC Filings

    View All

    SEC Form 6-K filed by AstraZeneca PLC

    6-K - ASTRAZENECA PLC (0000901832) (Filer)

    2/10/26 11:55:10 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    2/6/26 6:06:10 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by NIO Inc.

    6-K - NIO Inc. (0001736541) (Filer)

    2/5/26 8:40:28 AM ET
    $NIO
    Auto Manufacturing
    Industrials

    $AIH
    $AZN
    $BLCT
    $BTCM
    Leadership Updates

    Live Leadership Updates

    View All

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Vistagen Appoints Nick Tressler as Chief Financial Officer

    Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced the appointment of Nick Tressler as Chief Financial Officer (CFO), effective today, December 1, 2025. "I am excited to welcome Nick to Vistagen as our CFO. His financial and strategic acumen and extensive operational experience in the biopharmaceutical industry will be instrumental as we accelerate into our next phase," said President and Chief Executive Officer of Vistagen, Shawn Singh. "I look forward to his contributions to our leadership team and the po

    12/1/25 8:30:00 AM ET
    $AZN
    $SENS
    $VTGN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    SOLAI Limited Joins RWA Alliance as a Founding Member to Advance Tokenization of Green Energy Assets

    AKRON, Ohio, Oct. 21, 2025 /PRNewswire/ -- SOLAI Limited (NYSE: SLAI) ("SOLAI" or the "Company"), a leading technology-driven cryptocurrency infrastructure company (previously known as "BIT Mining"), today announced that it has officially joined the Real-World Assets (RWA) Alliance as one of its founding members. The RWA Alliance is dedicated to solving critical industry pain points – such as asset liquidity and opaque valuation – by promoting the tokenization of real-world assets. By leveraging blockchain technology to standardize, divide, and bring transparency to physical assets, the Alliance aims to open up new pathways for the digital transformation of the green energy sector through r

    10/21/25 6:00:00 AM ET
    $BTCM
    EDP Services
    Technology

    $AIH
    $AZN
    $BLCT
    $BTCM
    Financials

    Live finance-specific insights

    View All

    AstraZeneca results: FY and Q4 2025

    Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period AstraZeneca: Revenue and EPS summary   FY 2025 % Change Q4 2025 % Change   $m Actual CER1 $m Actual CER - Product Sales 55,573 9 9 14,538 9 7 - Alliance Revenue 3,067 39 38 959 34 33 Product Revenue2 58,640 10 10 15,497 10 8 Collaboration Revenue 99 (89) (89) 6 (99) (99) Total Revenue 58,739 9 8 15,503 4

    2/10/26 7:00:00 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    51Talk Online Education Group Announces Third Quarter 2025 Results

    SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial and Operating Highlights Gross billings[1] for the third quarter of 2025 were US$40.5 million, a 104.6% growth from US$19.8 for the third quarter of 2024.Net revenues for the third quarter of 2025 were US$26.3 million, an 87.5% increase from US$14.0 million for the third quarter of 2024.The number of quarterly active students with attended lesson consumption for the third quarter of 2025 wa

    12/8/25 6:30:00 AM ET
    $COE
    Other Consumer Services
    Real Estate

    51Talk Online Education Group to Report Third Quarter 2025 Financial Results on Monday, December 8, 2025

    Earnings Call Scheduled for 8:00 a.m. ET on December 8, 2025 SINGAPORE, Dec. 3, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE:COE), a global online education platform with core expertise in English education, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2025 on Monday, December 8, 2025, before the open of U.S. markets. The Company's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on December 8, 2025 (9:00 p.m. Singapore/Beijing/Hong Kong time on December 8, 2025). Dial-in details for the earnings conference call are as follows: United States Toll: 1-888-34

    12/3/25 4:01:00 PM ET
    $COE
    Other Consumer Services
    Real Estate

    $AIH
    $AZN
    $BLCT
    $BTCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

    SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

    12/17/24 4:07:04 PM ET
    $COE
    Other Consumer Services
    Real Estate

    SEC Form SC 13D filed by Quhuo Limited

    SC 13D - QUHUO Ltd (0001781193) (Subject)

    10/15/24 7:19:18 PM ET
    $QH
    Real Estate

    SEC Form SC 13D filed by Quhuo Limited

    SC 13D - QUHUO Ltd (0001781193) (Subject)

    10/15/24 7:17:52 PM ET
    $QH
    Real Estate